Skip to main content
TipRanks
Go Ultimate75% OFF

MRT Inc. (6034) AI Stock Analysis

1 Followers
JP:6034

MRT Inc.

(TSE/TYO:6034)

Select Model
Rating:58Neutral
Price Target:JPY 576.00â–²(3.97% Upside)
Action:reiterated
Date:11/20/26

MRT Inc.'s moderate score is anchored by its pristine balance sheet, aggressive debt reduction, and steady cash generation, which greatly minimize downside financial risk. However, top-line revenue stagnation, a premium valuation (31.36 P/E), and overhead long-term technical resistance significantly cap near-term upside potential.

Positive Factors
Low leverageVery low leverage reduces financial risk and preserves flexibility for investment, operations, or resilience during weaker trading conditions. Debt reduction from 2024 further strengthens the balance sheet, giving MRT greater capacity to manage its business without heavy financing pressure.
Negative Factors
Declining revenueSlightly declining revenue indicates that demand or business volume has not yet returned to a durable growth path. Without renewed top-line expansion, MRT may have less operating leverage, making sustained improvement in earnings and margins more difficult.

MRT Inc. (6034) vs. iShares MSCI Japan ETF (EWJ)

-30%-20%-10%0%10%20%30%JP:6034-16.69%EWJ+6.46%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 3.03B
Dividend Yield
―
Average Volume (3M)
14.06K
Price to Earnings (P/E)
31.8
Beta (1Y)
0.22
Revenue Growth
-6.69%
EPS Growth
―
Country
Japan
Employees
307
Sector
Healthcare
Sector Strength
51
Industry
Specialty Business Services

MRT Inc. Business Overview & Revenue Model

Company Description

MRT Inc. operates a medical information platform. It provides Gaikin, a recruitment service specializing in part-time physicians; career, a job change support service for doctors; re:ray, a one stop outsourcing service; Door., an app to connect netwo...

MRT Inc. Financial Statement Overview

Summary

Presents a mixed financial profile featuring an exceptionally resilient balance sheet with negligible debt (D/E ratio of 0.08) and positive free cash flows. This stability is heavily offset by operational headwinds, specifically a continued decline in revenue and razor-thin profit margins of 2.36%.

Income Statement

45Neutral

Balance Sheet

85Very Positive

Cash Flow

65Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue3.99B4.19B4.17B5.41B8.74B4.47B
Gross Profit2.52B2.60B2.48B3.27B5.41B3.37B
EBITDA405.98M331.35M165.42M1.20B3.16B1.61B
Net Income94.07M55.77M-309.16M518.36M2.16B774.49M
Balance Sheet
Total Assets6.24B6.48B6.75B6.47B8.16B4.98B
Cash, Cash Equivalents and Short-Term Investments1.51B1.67B2.61B3.78B4.89B1.01B
Total Debt392.84M552.97M1.05B641.79M875.86M1.04B
Total Liabilities1.52B1.83B2.12B1.76B3.67B2.69B
Stockholders Equity4.72B4.65B4.52B4.58B4.39B2.22B
Cash Flow
Free Cash Flow275.82M409.83M461.79M-208.76M4.50B-308.61M
Operating Cash Flow298.07M417.84M503.04M-193.58M4.51B-298.89M
Investing Cash Flow-185.28M-623.37M-1.84B-243.61M-431.11M-206.51M
Financing Cash Flow-431.30M-730.16M161.77M-669.19M-203.98M-67.49M

MRT Inc. Technical Analysis

Technical Analysis SentimentPositive
Last Price554.00

Price Trends

50DMA545.62Positive
100DMA589.15Negative
200DMA610.89Negative

Market Momentum

MACD-7.63Negative
RSI61.46Neutral
STOCH76.45Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6034, the sentiment is Positive. The current price of 554.00 is above the 20-day moving average (MA) of 503.15, above the 50-day MA of 545.62, and below the 200-day MA of 610.89, indicating a neutral trend. The MACD of -7.63 indicates Negative momentum. The RSI at 61.46 is Neutral, neither overbought nor oversold. The STOCH value of 76.45 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6034.

MRT Inc. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

JP:6034 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:6034JP:603458NeutralJPY 3.09B31.77――-6.69%―
JP:9218JP:921852NeutralJPY 7.94B29.89―1.35%34.18%-32.29%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
JP:3628JP:362849NeutralJPY 9.76B104.43――6.18%95.42%
JP:4438JP:443847NeutralJPY 2.16B-4.75――34.13%35.54%

* Healthcare Sector Average

Performance Comparison

-20%0%20%40%JP:6034JP:3628JP:4438JP:9218JP:366ADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:6034 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:6034MRT Inc.554.00-111.00-16.69%
JP:3628Data Horizon Co., Ltd.778.00260.0050.19%
JP:4438Welby Inc.257.00-38.00-12.88%
JP:9218Mental Health Technologies Co. Ltd.743.00-105.19-12.40%
JP:366AWellness Communications Corporation998.00-232.66-18.91%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 20, 2026